MnexSpike Covid -19 Vaccine FDA Approval in Usa Updates Moderna Ceo Stephane Bansel Limited Use Not Replacement – Amar Ujala Hindi News Live – Covid -19 Vaccine: COVID -19 Vaccine: The new vaccine in America in America

MnexSpike Covid -19 Vaccine FDA Approval in Usa Updates Moderna Ceo Stephane Bansel Limited Use Not Replacement – Amar Ujala Hindi News Live – Covid -19 Vaccine: COVID -19 Vaccine: The new vaccine in America in America

The US has approved Modarna’s new Kovid-19 vaccine mnexspike late night (local time) on Friday (local time). It is a new generation vaccine. It is made in low doses. This vaccine is only fifth of the existing spikewax dose. However, boundaries have been imposed on those using it. Not everyone can use this vaccine.

Trending videos

Modarna CEO Stephen Bainll said in a statement on Saturday (local time) that the approval of this vaccine will help in protecting people who are seriously ill from Kovid-19.

Also read: US: India-China will be charged 500% tariff on purchasing Russian oil; American senator Bluemethal warns

Vaccine will be given to these people

Food and Drug Administration (FDA) has given approval for the use of this vaccine to all adults aged 65 years and above. In addition, people between the ages of 12 and 64, who have already have a serious disease, can be able to use this vaccine, which can cause them to be more at risk of coronavirus. This is the same limit as the FDA set in the license for another Kovid-19 vaccine option from competitive Novaax. These restrictions are different from the way the US handle the Kovid-19 vaccines by the US, which reflects the suspicion of vaccines of Health Minister Robert F. Kennedy Junior and other Trump officials.

Also read: US TARIFS: Strict message from Donald Trump- Become the entire car and parts in America, warning to Tesla too

Study done on 11400 people over 12 years of age

These restrictions are not on Modarna’s existing vaccines. It has been used for all people aged 6 months and above for a long time. Modarna said that this vaccine was tried on 11,400 people above the age of 12. This vaccine was compared with the current vaccine. The company found that the new vaccine is safe and is better than the previous vaccine in terms of effect, or even better than in some cases.

The news came at a time when the Trump administration stopped the funding being given to Modernna to develop a vaccine against the potential epidemic flu virus, including the Bird Flu (H5N1), while the initial study results were good.

Related video

(Tagstotranslate) America (T) Moderna (T) FDA (T) Covid 19 vaccine (T) World News in Hindi (T) World News in Hindi (T) World Hindi News (T) America (T) America (T) Modern (T) Moder

Source link